{
  "ticker": "DSGN",
  "company_name": "Design Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06772870",
      "title": "A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1",
      "condition": "Friedreich Ataxia",
      "start_date": "2025-02",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Design Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06874010",
      "title": "A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Friedreich Ataxia",
      "start_date": "2025-06",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Design Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07024693",
      "title": "DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Fuchs Endothelial Corneal Dystrophy, Fuchs",
      "start_date": "2025-07-30",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Design Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05285540",
      "title": "Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Friedreich Ataxia",
      "start_date": "2022-03-11",
      "completion_date": "2022-12-19",
      "enrollment": 0,
      "sponsor": "Design Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05573698",
      "title": "Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Friedreich Ataxia",
      "start_date": "2022-09-27",
      "completion_date": "2023-08-25",
      "enrollment": 0,
      "sponsor": "Design Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 5,
    "by_phase": {
      "PHASE1": 3,
      "PHASE1, PHASE2": 1,
      "PHASE2": 1
    },
    "by_status": {
      "NOT_YET_RECRUITING": 1,
      "RECRUITING": 2,
      "COMPLETED": 2
    },
    "active_trials": 2,
    "completed_trials": 2,
    "conditions": [
      "Friedreich Ataxia",
      "Fuchs Endothelial Corneal Dystrophy, Fuchs"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:01.734709",
    "search_query": "Design Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Design+Therapeutics,+Inc."
  }
}